Belmont, MA, United States of America

Latika Singh

USPTO Granted Patents = 3 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
3 patents (USPTO):

Title: Innovations of Latika Singh

Introduction

Latika Singh is a prominent inventor based in Belmont, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of three patents to her name, her work has the potential to impact various therapeutic applications.

Latest Patents

Latika Singh's latest patents include innovative antibodies specific for immunoglobulin-like transcript 3 (ILT3). These humanized, non-promiscuous monoclonal antibodies are also known as Leukocyte immunoglobulin-like receptor subfamily B member 4 (LILRB4). The patents describe their uses and applications in medical treatments, showcasing her expertise in antibody engineering.

Career Highlights

Latika Singh is currently employed at Merck Sharp & Dohme Corporation, where she continues to advance her research and development efforts. Her work at this leading pharmaceutical company allows her to collaborate with other experts in the field and contribute to groundbreaking innovations.

Collaborations

Some of her notable coworkers include Michael A Meehl and Philip E Brandish. Their collaboration fosters a dynamic environment for innovation and research, enhancing the potential for impactful discoveries.

Conclusion

Latika Singh's contributions to biotechnology through her patents and work at Merck Sharp & Dohme Corporation highlight her role as a leading inventor in her field. Her innovative approaches to antibody development are paving the way for future advancements in medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…